期刊簡介預計審稿時間： 約3月

The aim of the European Journal of Nuclear Medicine and Molecular Imaging is to provide a forum for the exchange of clinical and scientific information for the imaging community and allied professions involved in the functional, metabolic and molecular investigation of diseases. The European Journal of Nuclear Medicine and Molecular Imaging will remain of primary interest to those practicing the field of imaging, radiopharmaceutical therapy and image guided therapy. The field of interest includes advanced imaging analyses techniques and artificial intelligence application in the field of imaging. Reports on original works related to physics, dosimetry, radiation biology, radiochemistry and pharmacy, will be considered in the field of interest of the EJNMMI. The Journal will welcome original material reflecting the field of molecular imaging probes, reporter gene assays, cell trafficking, targeting of endogenous gene expression and antisense methodologies.

The Journal will continue to publish in depth Reviews of topical interest, Short communications, Controversies, interesting images and Letters to the editor. Case reports are not published.

The journal publishes the following article types:

Original article,

Review article,

Letter to the Editor,

Guidelines,

Controversies,

Image of the month,

Short Communications,

Editorials

《歐洲核醫學與分子成像雜志》旨在為影像界和相關專業提供一個交流臨床和科學信息的論壇，這些專業涉及疾病的功能、代謝和分子研究。《歐洲核醫學與分子成像雜志》仍將主要吸引那些從事成像、放射性藥物治療和圖像引導治療領域的人士。該領域包括先進的成像分析技術和人工智能在成像領域的應用。與物理學、劑量測定、放射生物學、放射化學和藥學相關的原創作品報告將被納入 EJNMMI 的關注領域。該雜志將歡迎反映分子成像探針、報告基因檢測、細胞運輸、內源性基因表達靶向和反義方法領域的原創材料。

該雜志將繼續發表深度專題評論、簡短通訊、爭議、有趣的圖像和致編輯的信。病例報告不發表。

本期刊發表以下類型的文章：

原創文章，

評論文章，

致編輯的信，

指南，

爭議，

本月圖片，

簡短通訊，

社論

《European Journal Of Nuclear Medicine And Molecular Imaging》(歐洲核醫學與分子成像雜志)編輯部通訊方式為SPRINGER, 233 SPRING ST, NEW YORK, USA, NY, 10013。如果您需要協助投稿或潤稿服務，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務十年，熟悉發表政策，可為您提供一對一投稿指導，避免您在投稿時頻繁碰壁，節省您的寶貴時間，有效提升發表機率，確保SCI檢索（檢索不了全額退款）。我們視信譽為生命，多方面確保文章安全保密，在任何情況下都不會泄露您的個人信息或稿件內容。